Market Datavs. 1 year ago
30-year mortgage6.58%▼ -0.16 pts15-year mortgage5.96%▲ +0.09 pts10-year Treasury4.69%▲ +0.26 ptsMortgage spread1.89 pts▼ -0.42 ptsMedian list price$430k▼ -2.5%List $/sqft$228▼ -2.1%Days on market53 +0 daysActive listings1.1M▲ +1.9%New listings463k▲ +2.4%Pending sales506k▲ +4.9%Housing starts1.43M▲ +3.5%Building permits1.37M▼ -1.8%New-home sales628k▼ -5.6%Existing-home sales4.09M▲ +2.8%Months of supply9.3▲ +0.3 moMortgage delinquency1.89%▲ +0.12 pts
as of Jul 2026
Commercial Real Estate

NYC Halts Second Office-to-Residential Conversion in a Month After Pfizer Building Scare

New York City halted construction at GFP Real Estate's 222 Broadway office-to-residential conversion for unreported structural cracks, the second such stop-work order in a month.

NYC Halts Second Office-to-Residential Conversion in a Month After Pfizer Building Scare

New York City’s Department of Buildings has halted construction at 222 Broadway, GFP Real Estate’s office-to-residential conversion in lower Manhattan, after inspectors found the project’s contractor and engineer failed to report cracks that developed in structural beams. It is the second office-to-residential conversion in the city halted by DOB this month.

DOB found that Leeding Builders Group, the project’s contractor, and DeSimone Consulting Engineers, the engineering firm, did not properly report cracks that appeared in two concrete beams on the building’s newly added top floor, according to Crain’s New York Business. GFP Real Estate is converting the 32-story tower, a former home to Bank of America and WeWork, into a luxury residential building with nearly 800 units.

Second halt follows Pfizer HQ structural emergency

The 222 Broadway stop-work order follows an earlier DOB halt this month at the former Pfizer headquarters conversion in Midtown Manhattan, where two buckled structural columns prompted an evacuation and an emergency stabilization effort. That project involves converting two office buildings, one built in 1909 and the other in the 1960s, into roughly 1,600 apartments by adding more than a dozen stories atop the older structure and redesigning and expanding the other, according to wire service reporting.

The back-to-back incidents have prompted city regulators to widen scrutiny of adaptive-reuse conversion projects across New York, a construction category that has grown rapidly as developers convert underused office towers into housing amid soft office demand and a citywide push for more residential supply.

What it means

Verified facts: DOB halted work at both 222 Broadway and the former Pfizer headquarters this month over structural reporting and stabilization issues tied to office-to-residential conversions.

RealtyWire analysis: The two halts within weeks of each other point to a systemic challenge in adaptive-reuse construction, where older office structures are being significantly reengineered to carry additional residential floors and different load patterns than they were originally designed for. Given the volume of office-to-residential conversions now underway or planned in New York and other cities, the incidents could prompt closer inspection protocols industrywide.

What to watch: Whether DOB imposes broader reporting requirements on active conversion projects citywide, and whether GFP Real Estate’s construction timeline and costs at 222 Broadway are materially affected by the halt.

Source: Crain’s New York Business

Related coverage: Annual Home Price Appreciation Hits Fastest Pace Since August 2025 · Opus Starts Construction on 898,500-Square-Foot Spec Industrial Park in Canal Winchester · NYC Rent Board Data Reignite Debate Over Who Rent Stabilization Helps

βœ‰

Stay ahead of the market.

Get expert insights, market updates, and new opportunities delivered to your inbox.

RealtyWire Newsletter Signup
We respect your privacy. Unsubscribe anytime.